CSGP vs DOC
CoStar Group vs Healthpeak Properties — AI-powered side-by-side comparison
VS
DOC
Healthpeak Properties
64
Buy
| Metric | CSGP | DOC |
|---|
| AI Score |
63
|
64
|
| Price |
$31.13
|
$20.50
|
| P/E Ratio |
169.41×
|
58.60×
|
| ROE |
0.1%
|
1.0%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
76.5%
|
2.5%
|
| Debt / Equity |
0.15×
|
1.32×
|
| Dividend Yield |
0.0%
|
5.9%
|
| RSI (14) |
66.9
|
31.1
|
| Beta |
0.731
|
0.991
|
| Expected Upside |
+122.2%
|
+1.6%
|
AI Committee View
Current Innellis committee reasoning for CSGP versus DOC.
DOC leads by 1 points.
DOC scores 64/100 (Buy) versus CSGP at 63/100 (Buy).
CSGP Committee View
40% agreement
5 analysts
The committee is genuinely divided. Growth Analyst sees a compelling case — 5 consecutive earnings beats -- consistent execution. Risk Analyst remains cautious — bollinger bandwidth of 15.5% signals elevated volatility. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- Bollinger bandwidth of 15.5% signals elevated volatility — Risk
DOC Committee View
50% agreement
4 analysts
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull Case
- 4 consecutive earnings beats -- consistent execution — Growth
- Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement — Technical
- VIX regime is low -- calm backdrop supports risk-taking — Macro
Bear Case
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
- MACD histogram negative -- bearish momentum — Technical
- Price trading below the lower Bollinger Band -- stretched to the downside — Technical